Volume 2, Issue 2: Beyond Basal Insulin: Combination Therapy with GLP-1 RAs
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 2, Issue 2)
Target Audience
Nurses and health care professionals involved in the care of patients with diabetes.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to describe new findings in:
- Describe the glucose lowering effects of GLP-1 receptor agonists (GLP-1 RA) added to basal insulin
- Compare the safety and efficacy of GLP-1 RA and prandial insulin in combination with basal insulin
- Identify the physiologic differences between continuous and intermittent GLP-1 RA, alone and in combination with basal insulin
Kathleen Dungan, MD, MPH
Associate Professor, Associate Division Director for Clinical Services
Division of Endocrinology, Diabetes and Metabolism
The Ohio State University
Columbus, Ohio
Available Credit
- 1.00 ANCC
- 1.00 Attendance